Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:499-504
Published online before print January 19, 2006, doi: 10.1161/01.RES.0000204451.88147.96
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
98/4/499    most recent
01.RES.0000204451.88147.96v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takayama, K.
Right arrow Articles by Libby, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takayama, K.
Right arrow Articles by Libby, P.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
(Circulation Research. 2006;98:499.)
© 2006 American Heart Association, Inc.


Molecular Medicine

A Novel Prostaglandin E Receptor 4–Associated Protein Participates in Antiinflammatory Signaling

Kiyoshi Takayama, Galina K. Sukhova, Michael T. Chin, Peter Libby

From the Leducq Center for Cardiovascular Research (K.T., G.K.S., P.L.); and Cardiovascular Division (M.T.C.), Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass. Current address for K.T.: Medicinal Research Center, Taisho Pharmaceutical Company, Ltd, Saitama, Japan.

Correspondence to Peter Libby, MD, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 7, Boston, MA 02115. E-mail plibby{at}rics.bwh.harvard.edu

Prostaglandin E2 exerts an antiinflammatory action by ligation of the heptahelical receptor EP4 in human macrophages. Because the mechanism by which EP4 receptor stimulation suppresses inflammatory activation in macrophages remains undefined, we sought interactors with the carboxyl-terminal cytoplasmic domain of the EP4 receptor. Yeast 2-hybrid screening of the human bone marrow cDNA library with the EP4 receptor as a bait identified a cDNA clone encoding a 669-amino acid protein, designated here as EP4 receptor-associated protein (EPRAP), which contains 8 ankyrin motifs that might recruit other signaling molecules. EPRAP bound to the full-length EP4 receptor in HEK293 cells cotransfected with V5-tagged EPRAP and FLAG-tagged EP4 receptor cDNA, as anti-FLAG antibody coimmunoprecipitated EPRAP with the EP4 receptor from the lysates of cotransfected cells. Human macrophages derived from peripheral blood monocytes expressed an approximately 70-kDa protein detected by Western blotting with a polyclonal anti-EPRAP antibody. Fluorescence immunohistochemistry colocalized EPRAP with the EP4 receptor in human atheromata. Interference with EPRAP function by small interference RNA limited prostaglandin E2–mediated suppression of chemokine expression in macrophages activated with lipopolysaccharide and tumor necrosis factor {alpha}. In conclusion, the antiinflammatory action of prostaglandin E2 in macrophages involves EPRAP that associates directly with the cytoplasmic tail of EP4 receptor.


Key Words: macrophage • arteriosclerosis • two-hybrid system techniques • prostaglandin receptor • ankyrin repeat




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. M. Aronoff, C. Lewis, C. H. Serezani, K. A. Eaton, D. Goel, J. C. Phipps, M. Peters-Golden, and P. Mancuso
E-Prostanoid 3 Receptor Deletion Improves Pulmonary Host Defense and Protects Mice from Death in Severe Streptococcus pneumoniae Infection
J. Immunol., August 15, 2009; 183(4): 2642 - 2649.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Hishikari, J.-i. Suzuki, M. Ogawa, K. Isobe, T. Takahashi, M. Onishi, K. Takayama, and M. Isobe
Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury
Cardiovasc Res, January 1, 2009; 81(1): 123 - 132.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.O. Goodarzi, J.F. Maher, J. Cui, X. Guo, K.D. Taylor, and R. Azziz
FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome
Hum. Reprod., December 1, 2008; 23(12): 2842 - 2849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Minami, K. Shimizu, Y. Okamoto, E. Folco, M.-L. Ilasaca, M. W. Feinberg, M. Aikawa, and P. Libby
Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-{kappa}B1 and Attenuates Macrophage Activation
J. Biol. Chem., April 11, 2008; 283(15): 9692 - 9703.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
H. Oka, M. Miyauchi, K. Sakamoto, S. Moriwaki, S. Niida, K. Noguchi, M.J. Somerman, and T. Takata
PGE2 Activates Cementoclastogenesis by Cementoblasts via EP4
Journal of Dental Research, October 1, 2007; 86(10): 974 - 979.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. J. Lorenowicz, M. Fernandez-Borja, and P. L. Hordijk
cAMP Signaling in Leukocyte Transendothelial Migration
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1014 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Wang, A. M. Zukas, Y. Hui, E. Ricciotti, E. Pure, and G. A. FitzGerald
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis
PNAS, September 26, 2006; 103(39): 14507 - 14512.
[Abstract] [Full Text] [PDF]